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The first formal organizational meeting of the International Association for the Study ofLung Cancer (IASLC) was held in October of 1974 in Florence, Italy, where also the
bylaws of the organization were unanimously accepted. Since then, steady growth and
expansion have taken place, changing the IASLC from a tightly knitted association with
a modest budget that relied on input from the members to a professional organization that
arranges biannual world conferences, with more than 5000 participants at the latest one in
Barcelona this year. From the beginning, the world conference has been a key event for
the IASLC, providing the possibility for exchange of the most recent knowledge on the
disease. In addition, these meetings included, particularly in the early years, numerous
social events, and lifelong friendships were developed, with each conference establishing
a special cultural atmosphere characteristic for the country it was arranged in.
Over the years, lung cancer has become a pandemic, killing more than 1.5 million
people annually and displaying drastic changes in its biological pattern. The marked
increase of lung cancer occurs especially in heavily populated countries, such as China
and India, following the pattern of cigarette consumption, whereas the incidence is
decreasing in certain Western countries. Similar to the changes in smoking habits, the
disease entity has changed, with a marked increase of adenocarcinomas compared with
squamous cell carcinoma, especially in women. In the same period, our knowledge of the
biology of lung cancer has increased, and this has resulted in improvements in the
management of lung cancer patients, with more patients receiving multidisciplinary
treatment, including second- and third-line chemotherapy, which was unheard of just 5
years ago. We should not forget, however, that the 5-year overall survival remains at 15%,
a figure that has been rather steady for many years.
The IASLC early recognized the need to spread the message about lung cancer by
arranging or supporting meetings, workshops, symposia, and colloquiums—altogether, 58
in the period 1981 through 2001 in 21 countries covering all aspects from prevention to
biology and treatment. Also, a regular contact was established to the members, initially as
a newsletter, but since 1985 as a regular journal entitled Lung Cancer, which was one of
the first journals to specialize on one disease. The journal is now published on a monthly
basis. Again, the global aspect of the IASLC is emphasized. The recessivity of spreading
information about lung cancer has also been supported by the publication of the IASLC
Textbook of Lung Cancer, published first in 1999 and with a subsequent Chinese edition
in 2000.
Other important aspects of IASLC activities have included the establishment of
fellowships enabling young scientists to focus on research in lung cancer, and the Tokyo
Declaration on Tobacco in 2000. Also, the Association plays a key role in the World
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Health Organization classification of lung cancer and in a
new staging system together with International Union
Against Cancer based on data from IASLC members all over
the world.
The Association is thus developing according to the
need of the members, and I hope that the IASLC will
continue to play an inspiring key role in the overall battle
against this dreadful disease—lung cancer.
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